Author

V. Monteil

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cell Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

A. Mirazimi· 4 shared J. M. Penninger· 2 shared A. Ambikan· 1 shared A. Balkema-Buschmann· 1 shared A. Banerjea· 1 shared A. Dorhoi· 1 shared A. Hagelkrueys· 1 shared A. Leopoldi· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

A. Mirazimi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Reconstructing bat antiviral immunity using epithelial organoids

M. J. Kellner, P. Zelger, V. Monteil, G. Pei, M. Onji, K. Nayak, M. Zilbauer, A. Balkema-Buschmann, A. Dorhoi, A. Mirazimi, J. M. Penninger

This study uses bat epithelial organoids to investigate antiviral immunity differences between bats and humans, revealing unique interferon responses and implications for viral pathogenesis.

bioRxiv · Apr 5, 2024 · PreprintImmunology

Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor

T. Capraz, N. F. Kienzl, E. Laurent, J. W. Perthold, E. Foederl-Hoebenreich, C. Gruenwald-Gruber, D. Maresch, V. Monteil, J. Niederhoefer, G. Wirnsberger, A. Mirazimi, K. Zatloukal, L. Mach, J. M. Penninger, C. Oostenbrink, J. Stadlmann

This study engineers ACE2 glycosylation to enhance its binding to SARS-CoV-2 Spike protein, resulting in a more potent decoy receptor for COVID-19 treatment.

bioRxiv · Aug 31, 2021Biochemistry

A diabetic milieu increases cellular susceptibility to SARS-CoV-2 infections in engineered human kidney organoids and diabetic patients

E. Garreta, P. Prado, M. L. Stanifer, V. Monteil, C. Hurtado del Pozo, A. Ullate-Agote, A. Vilas-Zornoza, J. P. Romero, G. Jonsson, R. Oria, A. Leopoldi, A. Hagelkrueys, D. Moya-Rull, F. Gonzalez, A. Marco, , N. Montserrat

This study shows that a diabetic environment increases SARS-CoV-2 susceptibility in kidney organoids and patients by upregulating ACE2, which is critical for viral replication.

bioRxiv · Aug 13, 2021 · PreprintCell Biology

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo Hemorrhagic Fever Viruses for novel therapeutic target

U. Neogi, N. Elaldi, S. Appelberg, A. Ambikan, E. Kennedy, S. D. Dowall, B. K. Bagci, S. Gupta, J. E. Rodriguez, S. Svensson-Akusjärvi, V. Monteil, A. Vegvari, R. Benfeitas, A. Banerjea, F. Weber, , A. Mirazimi

This study uses multi-omics approaches to analyze host-viral interactions in CCHFV infection, identifying metabolic reprogramming and interferon-mediated antiviral mechanisms as potential therapeutic targets.

bioRxiv · Dec 10, 2020Microbiology